Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3543361rdf:typepubmed:Citationlld:pubmed
pubmed-article:3543361lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:3543361lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:3543361lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:3543361lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:3543361lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:3543361lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:3543361lifeskim:mentionsumls-concept:C0075019lld:lifeskim
pubmed-article:3543361lifeskim:mentionsumls-concept:C0628973lld:lifeskim
pubmed-article:3543361pubmed:issue7lld:pubmed
pubmed-article:3543361pubmed:dateCreated1987-3-11lld:pubmed
pubmed-article:3543361pubmed:abstractTextSpirohydantoin mustard (SHM), a central nervous system directed nitrogen mustard with anticancer activity, was metabolized in the presence of mouse liver postmitochondrial supernatant (9000g fraction) to a nonpolar alkylating metabolite. The metabolite was isolated by thin-layer chromatography of chloroform or ethyl acetate extracts of incubation mixtures, and its structure was established by mass spectral analysis, synthesis, and cochromatography. The metabolite, spirohydantoin aziridine, was mutagenic for Salmonella typhimurium TA1535 in the Ames assay but inactive as an antitumor agent against P388 leukemia in vivo.lld:pubmed
pubmed-article:3543361pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3543361pubmed:languageenglld:pubmed
pubmed-article:3543361pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3543361pubmed:citationSubsetIMlld:pubmed
pubmed-article:3543361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3543361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3543361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3543361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3543361pubmed:statusMEDLINElld:pubmed
pubmed-article:3543361pubmed:monthJullld:pubmed
pubmed-article:3543361pubmed:issn0022-2623lld:pubmed
pubmed-article:3543361pubmed:authorpubmed-author:StruckR FRFlld:pubmed
pubmed-article:3543361pubmed:authorpubmed-author:SulingW JWJlld:pubmed
pubmed-article:3543361pubmed:authorpubmed-author:RiceL SLSlld:pubmed
pubmed-article:3543361pubmed:authorpubmed-author:KirkM CMClld:pubmed
pubmed-article:3543361pubmed:issnTypePrintlld:pubmed
pubmed-article:3543361pubmed:volume29lld:pubmed
pubmed-article:3543361pubmed:ownerNLMlld:pubmed
pubmed-article:3543361pubmed:authorsCompleteYlld:pubmed
pubmed-article:3543361pubmed:pagination1319-21lld:pubmed
pubmed-article:3543361pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:meshHeadingpubmed-meshheading:3543361-...lld:pubmed
pubmed-article:3543361pubmed:year1986lld:pubmed
pubmed-article:3543361pubmed:articleTitleIsolation, synthesis, and antitumor evaluation of spirohydantoin aziridine, a mutagenic metabolite of spirohydantoin mustard.lld:pubmed
pubmed-article:3543361pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3543361pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:3543361lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3543361lld:pubmed